AUSTIN, Texas, Sept. 10, 2012 /PRNewswire/ -- Luminex
Corporation (NASDAQ: LMNX), today announced that it will host
Planet xMAP Europe 2012, its
annual European multiplexing technology symposium, October 10-11, 2012 at the Grimaldi Forum in the
Principality of Monaco.
Luminex anticipates attendance of over 500 scientists and
more than 40 scientific presentations to be addressed during the
10th anniversary event. The two-day program features
scientific sessions, workshops, discussion groups, exhibitions and
networking events with scientists and researchers from around the
world who are performing groundbreaking work in clinical
diagnostics and life science research using Luminex's technology
platforms.
(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO
)
"We are excited to have scientists from around the world share
their latest research and to see the continued growth in new
applications for multiplexing technology," said Paul C. Ladestein,
General Manager European Operations for Luminex. "The focus this
year is on new developments in the areas of newborn screening,
infectious disease, immunology-monitoring, human genetics, protein
and nucleic acid research. Planet xMAP Europe is always an excellent opportunity for
leading scientists to gather and exchange ideas on how xMAP
multiplexing technology is revolutionizing their laboratories and
research. Our 10th anniversary event highlights
the contributions our technology is making in advancing research
and healthcare around the globe."
Planet xMAP Europe 2012 will
feature two days of presentations with keynote lectures from:
- Dr. Jean William Pape,
Director and Founder of GHESKIO Centers (Haitian Study Group on
Kaposi's sarcoma and Opportunistic Infections) Haiti, Professor of Medicine at Weill Medical College of Cornell University in
New York
- Dr. Freda Miller, Cell
and molecular developmental neurobiologist at the Hospital for Sick
Children Research Institute, Professor at University of Toronto, Canada
Day One of Planet xMAP Europe 2012, Wednesday, 10 October, will focus
on Pathogen Detection, Gastrointestinal Infections, Respiratory
Viral Infections, and Newborn Screening
The morning session will include the following
presentations:
30 years experience in the fight against infectious
diseases in Haiti
Dr. Jean William Pape,
GHESKIO Centers,Weill Medical College of Cornell University, Haiti
Abstract
Multiplex Diagnosis Reveals New Challenges for Malaria
Elimination
Dr. Peter A. Zimmerman, Case
Western University, Cleveland, Ohio
Abstract
Rational multiplex serological screening system for common
pathogens using suspension arrays
Dr. Jonas Blomberg,
Clinical Microbiology, Academic Hospital, Uppsala, Sweden
Abstract
Preliminary findings of a Health Economic Study of the
Luminex xTAG® Gastrointestinal Pathogen Panel at Guy's & St.
Thomas' NHS trust 2011-12
Dr. Eugene Halligan, Guy's
& St. Thomas' Hospital, London,
UK
Abstract
Newborn Screening: Current Situation and Future
Applications
Dr. David C. Kasper, Medical
University of Vienna, Vienna, Austria
Abstract
The afternoon session will feature three separate tracks focused
on Human Genetics, Immunology-Monitoring, and Pathogen
Detection.
Day Two of Planet xMAP Europe 2012, Thursday, 11 October, will focus
on Neural Stem Cells, Tumor Microenvironment, the Immune-Proteome,
and Cellular Systems
The morning session will include the following
presentations:
Neural stem cells: from development to
repair
Dr. Freda Miller, Hospital for Sick
Children Research Institute
Abstract
Chronic inflammatory and immunosuppressive conditions in
tumor microenvironment and their neutralization
Dr. Viktor Umansky, German Cancer
Research Center, Heidelberg and
University Hospital Mannheim, Germany
Abstract
Systematic high-throughput / high content analysis of the
immune-proteome using Luminex-based multiplex arrays
Dr. Peter Schulz-Knappe, Protagen
AG, Dortmund, Germany
Abstract
Capturing the Complexity of Cellular
Systems
Dr. John K. Westwick,
Odyssey Thera, Inc., San Ramon,
California
Abstract
The afternoon session will feature two separate tracks focused
on Genomic and Protein Research.
For detailed information regarding the Planet xMAP Europe 2012 symposium and agenda, or to
register online, please visit http://www.planetxmap.com .
About Luminex Corporation
Luminex is committed to applying its passion for innovation
toward advancing healthcare and research worldwide. The Company is
transforming global healthcare and life-science research through
the development, manufacturing and marketing of proprietary
instruments and assays utilizing xMAP® open-architecture,
multi-analyte platform, MultiCode® real-time polymerase chain
reaction (PCR), and multiplex PCR-based technologies, that deliver
cost-effective rapid results to clinicians and researchers.
Luminex's technology is commercially available worldwide and in use
in leading clinical laboratories as well as major pharmaceutical,
diagnostic, biotechnology and life-science companies. The Company
is meeting the needs of customers in markets as diverse as clinical
diagnostics, pharmaceutical drug discovery, biomedical research
including genomic and proteomic research, personalized medicine,
biodefense research and food safety. For further information on
Luminex Corporation and the latest advances in multiplexing using
award winning technology, please visit http://www.luminexcorp.com
.
Contacts
|
|
Corporate:
|
Media:
|
Harriss T.
Currie
|
Mimi
Torrington
|
Chief
Financial Officer and Vice President, Finance
|
Director,
Marketing Communications
|
Luminex
Corporation
|
Luminex
Corporation
|
hcurrie@luminexcorp.com
|
mtorrington@luminexcorp.com
|
+1.512.219.8020
|
+1.512.219.8020
|
|
|
Investors:
|
Aaron
DeLucia:
|
Matthew
Scalo
|
Porter
Novelli
|
Sr.
Director, Investor Relations
|
Aaron.DeLucia@porternovelli.com
|
Luminex
Corporation
|
+1.512.241.2249
|
mscalo@luminexcorp.com
|
|
+1.512.219.8020
|
|
SOURCE Luminex Corporation